HIBRUKA (Orelabrutinib)

Approval for HIBRUKA (Orelabrutinib) in Singapore in MZL

Approval of HIBRUKA (Orelabrutinib) for the Treatment of R/R MZL in Singapore

Format

JPEG

Quelle:

InnoCare Pharma

Downloads